Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Simon Spichak, MSc
Study: In Women With the ‘Alzheimer’s Gene,’ HRT Linked to Cognition
Medicare Stands Firm: No Public Coverage for New Alzheimer’s Drugs
How Does the APOE4 Gene Affect My Alzheimer’s Risk?
Brain Bug? Clinical Trial Tests Antivirals to Treat Alzheimer’s
What Kind of Dementia Does Bruce Willis Have?
What Causes Alzheimer’s—and Is the Leading Theory ‘Too Big to Fail’?
Christiana Egi: Breaking Down Dementia’s Stigmas for the Young and Old
What Can Dolphins Teach Us About Alzheimer’s?
Leqembi Clinical Trials Aren’t Over—Half of Participants Will Get the Drug for Free
Cancer Appears to Reduce Dementia Risk – Here’s Why
How ‘Exercise Snacks’ Could Feed the Brain and Prevent Dementia
Can COVID-19 Cause Alzheimer’s or Dementia?
Lecanemab Approved: New Disease-Modifying Alzheimer’s Drug Leqembi on the Market
On the Brink of a Lecanemab FDA Decision, What Do We Know About the Drug’s Safety?
Beyond the Hype: What Does the Lecanemab News Mean for People with Alzheimer’s?
Previous
20
21
22
Next
Page load link
Go to Top